| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.MICPATH.2004.06.009 |
| P698 | PubMed publication ID | 15458778 |
| P2093 | author name string | E Diane Williamson | |
| Stephen J Elvin | |||
| P433 | issue | 4 | |
| P304 | page(s) | 177-184 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Microbial Pathogenesis | Q15766470 |
| P1476 | title | Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague | |
| P478 | volume | 37 |
| Q36237899 | A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen |
| Q41441607 | Antibodies and cytokines independently protect against pneumonic plague. |
| Q34045080 | Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa. |
| Q33310431 | Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells |
| Q35810279 | Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination. |
| Q36628038 | Current challenges in the development of vaccines for pneumonic plague |
| Q37355852 | D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague |
| Q35689282 | Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice |
| Q60584774 | Enterobacteria and host resistance to infection |
| Q93375305 | Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection |
| Q93015468 | Flagellin adjuvanted F1/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signatures |
| Q34334406 | Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis |
| Q41453869 | Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection |
| Q34633478 | HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model |
| Q34786724 | IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection |
| Q33584403 | Immune defense against pneumonic plague |
| Q40512106 | Immunology of Yersinia pestis Infection |
| Q36288336 | Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor |
| Q36594020 | Interaction between Yersinia pestis and the host immune system |
| Q34298699 | LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague |
| Q40008433 | Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague |
| Q38671761 | Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague |
| Q36372952 | Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague |
| Q84740727 | Plague |
| Q37745002 | Predictive models and correlates of protection for testing biodefence vaccines |
| Q37640118 | Prospects for new plague vaccines. |
| Q26823422 | Protecting against plague: towards a next-generation vaccine |
| Q33946563 | Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens. |
| Q41454706 | Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine. |
| Q41451838 | Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen |
| Q37688618 | Rational considerations about development of live attenuated Yersinia pestis vaccines |
| Q41432988 | Repertoire of HLA-DR1-restricted CD4 T-cell responses to capsular Caf1 antigen of Yersinia pestis in human leukocyte antigen transgenic mice |
| Q41455673 | Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague |
| Q41453072 | Sequential proteolytic processing of the capsular Caf1 antigen of Yersinia pestis for major histocompatibility complex class II-restricted presentation to T lymphocytes |
| Q37066697 | Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection |
| Q34380204 | TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. |
| Q41432452 | Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague. |
| Q38589273 | The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague |
| Q64112896 | Use of bioengineered human commensal gut bacteria-derived microvesicles for mucosal plague vaccine delivery and immunization |
| Q41459022 | Yersinia pestis V protein epitopes recognized by CD4 T cells |
| Q35091255 | Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague |
| Q41437577 | Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages |
| Q35073117 | YopP-expressing variant of Y. pestis activates a potent innate immune response affording cross-protection against yersiniosis and tularemia [corrected]. |
Search more.